El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) Other Operating Expense: E£342 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI:NIPH El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH
28 GF Score
Price E£372.30
! 4 Warning Signs
View Full Analysis

What is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Other Operating Expense?

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH +2.00% 28 Other Operating Expense is E£342 Mil as of Mar. 2026. GuruFocus rates CAI:NIPH with a GF Score™ of 28/100. The stock has 4 warning signs investors should review.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Other Operating Expense for the three months ended in Mar. 2026 was E£192 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was E£342 Mil.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's quarterly Other Operating Expense increased from Sep. 2025 (E£-1 Mil) to Dec. 2025 (E£44 Mil) and increased from Dec. 2025 (E£44 Mil) to Mar. 2026 (E£192 Mil).

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's annual Other Operating Expense increased from . 20 (E£0 Mil) to Jun. 2024 (E£46 Mil) and increased from Jun. 2024 (E£46 Mil) to Jun. 2025 (E£51 Mil).


El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Other Operating Expense Related Terms


El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Other Operating Expense Historical Data

* Premium members only.

The historical data trend for El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Other Operating Expense Chart

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Annual Data
Trend Jun24 Jun25
Other Operating Expense
46.34 50.75

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial 116.32 107.41 -0.54 43.98 191.59
CAI:NIPH
28GF Score
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was E£342 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of E£342 Mil mean?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a Other Operating Expense of E£342 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile and its competitors.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Other Operating Expense too high?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Other Operating Expense is E£342 Mil. Overall, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Other Operating Expense compare to ZTS and UTHR?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Other Operating Expense of E£342 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile and its competitors. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Other Operating Expense is E£342 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile stock overvalued right now?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a current Other Operating Expense of E£342 Mil. The current Other Operating Expense is E£342 Mil. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH), the current Other Operating Expense is E£342 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Business Description

Address Al-Sawah square, ElAmeria, Cairo, EGY
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile manufactures and markets pharmaceuticals, medicinal materials, chemical products and surgical threads and medical solutions.
28GF Score

Get the complete analysis for CAI:NIPH

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£372.30
Price